| Primary |
| Bipolar Disorder |
41.2% |
| Product Used For Unknown Indication |
19.6% |
| Bipolar I Disorder |
5.9% |
| Affective Disorder |
3.9% |
| Bipolar Ii Disorder |
3.9% |
| Drug Use For Unknown Indication |
3.9% |
| Metastatic Renal Cell Carcinoma |
3.9% |
| Mood Swings |
3.9% |
| Depression |
2.0% |
| Hypertension |
2.0% |
| Mania |
2.0% |
| Obsessive-compulsive Disorder |
2.0% |
| Osteoarthritis |
2.0% |
| Thyroid Disorder |
2.0% |
| Unevaluable Event |
2.0% |
|
| Therapeutic Agent Toxicity |
14.8% |
| Thyroid Disorder |
7.4% |
| Toxicity To Various Agents |
7.4% |
| Tremor |
7.4% |
| Weight Decreased |
7.4% |
| Bipolar Disorder |
3.7% |
| Coma |
3.7% |
| Depression |
3.7% |
| Drug Level Increased |
3.7% |
| Dyspepsia |
3.7% |
| Glomerulonephritis Chronic |
3.7% |
| Hospitalisation |
3.7% |
| Hypothyroidism |
3.7% |
| Incontinence |
3.7% |
| Muscular Weakness |
3.7% |
| Nausea |
3.7% |
| Neuropathy Peripheral |
3.7% |
| Neutrophil Count Decreased |
3.7% |
| Oral Pain |
3.7% |
| Pharmaceutical Product Complaint |
3.7% |
|
| Secondary |
| Bipolar Disorder |
29.6% |
| Ill-defined Disorder |
12.3% |
| Depression |
8.6% |
| Drug Use For Unknown Indication |
8.6% |
| Product Used For Unknown Indication |
6.2% |
| Bipolar I Disorder |
4.9% |
| Bipolar Ii Disorder |
3.7% |
| Mania |
3.7% |
| Nervousness |
3.7% |
| Self Injurious Behaviour |
3.7% |
| Smoking Cessation Therapy |
3.7% |
| Candidiasis |
2.5% |
| Drug Dependence |
2.5% |
| Insomnia |
2.5% |
| Mood Swings |
2.5% |
| Affective Disorder |
1.2% |
|
| Weight Decreased |
24.2% |
| Suicidal Ideation |
21.2% |
| Prothrombin Time Shortened |
9.1% |
| Diarrhoea |
6.1% |
| Vomiting |
6.1% |
| Cerebrovascular Accident |
3.0% |
| Medication Error |
3.0% |
| Neutrophil Count Decreased |
3.0% |
| Product Substitution Issue |
3.0% |
| Renal Disorder |
3.0% |
| Repetitive Speech |
3.0% |
| Skin Discolouration |
3.0% |
| Therapeutic Response Unexpected With Drug Substitution |
3.0% |
| Urine Ketone Body Present |
3.0% |
| Urticaria |
3.0% |
| Weight Increased |
3.0% |
|
| Concomitant |
| Bipolar Disorder |
29.9% |
| Depression |
10.4% |
| Anxiety |
9.9% |
| Sleep Disorder |
8.6% |
| Product Used For Unknown Indication |
8.4% |
| Insomnia |
3.3% |
| Schizophrenia |
3.2% |
| Pain |
2.9% |
| Headache |
2.6% |
| Bipolar I Disorder |
2.5% |
| Affective Disorder |
2.2% |
| Agitation |
2.1% |
| Mania |
2.1% |
| Ill-defined Disorder |
2.0% |
| Hypertension |
1.7% |
| Schizoaffective Disorder |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Irritability |
1.6% |
| Poor Quality Sleep |
1.6% |
| Restlessness |
1.6% |
|
| Weight Increased |
21.4% |
| Type 2 Diabetes Mellitus |
17.9% |
| Tremor |
6.9% |
| Upper Respiratory Tract Infection |
6.2% |
| Sciatic Nerve Neuropathy |
4.1% |
| Tardive Dyskinesia |
4.1% |
| Unevaluable Event |
4.1% |
| Vision Blurred |
4.1% |
| Vertigo |
3.4% |
| Vulvovaginal Pruritus |
3.4% |
| Drug Ineffective |
2.8% |
| Insomnia |
2.8% |
| Intentional Overdose |
2.8% |
| Type 1 Diabetes Mellitus |
2.8% |
| Urticaria |
2.8% |
| Diabetes Mellitus |
2.1% |
| Nausea |
2.1% |
| Pain |
2.1% |
| Restlessness |
2.1% |
| Sleep Apnoea Syndrome |
2.1% |
|
| Interacting |
| Bipolar Disorder |
50.0% |
| Smoking Cessation Therapy |
50.0% |
|
|
